CORONA, CA, May 29, 2009 (MARKETWIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty
pharmaceutical company, announced today that Mark Durand, Watson's
senior vice president and chief financial officer, will provide an
overview and update of the Company's business at the UBS Global
Specialty Pharmaceuticals Conference 2009 on Wednesday, June 3, 2009
at 1:30 p.m. London Daylight Saving Time (DST) (8:30 a.m. EDT).
This presentation will be webcast live and can be accessed on Watson
Pharmaceuticals' Investor Relations Web site at http://ir.watson.com.
The webcast can also be accessed at the following URL:
An archived version will be available for 30 days after the live
presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a global leader in the development
and distribution of pharmaceuticals with a broad portfolio of generic
products and a specialized portfolio of brand pharmaceuticals focused
on Urology, Women's Health and Nephrology/Medical.
For press releases and other company information, visit Watson
Pharmaceuticals' Web site at http://www.watson.com.
Watson Pharmaceuticals, Inc.
SOURCE: Watson Pharmaceuticals